Macrogol (polyethylene glycol) 4000 without electrolytes in the symptomatic treatment of chronic constipation: a profile of its use
Tóm tắt
Từ khóa
Tài liệu tham khảo
Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106(9):1582–91.
Tamura A, Tomita T, Oshima T, et al. Prevalence and self-recognition of chronic constipation: results of an internet survey. J Neurogastroenterol Motil. 2016;22(4):677–85.
Shafe AC, Lee S, Dalrymple JS, et al. The LUCK study: laxative usage in patients with GP-diagnosed constipation in the UK, within the general population and in pregnancy. An epidemiological study using the General Practice Research Database (GPRD). Ther Adv Gastroenterol. 2011;4(6):343–63.
Lindberg G, Hamid S, Malfertheiner P, et al. Constipation: a global perspective. Milwaukee: World Gastroenterology Organisation; 2010.
Koppen IJN, Vriesman MH, Saps M, et al. Prevalence of functional defecation disorders in children: a systematic review and meta-analysis. J Pediatr. https://doi.org/10.1016/j.jpeds.2018.02.029 (Epub 2018).
Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther. 2007;25(5):599–608.
Wald A, Sigurdsson L. Quality of life in children and adults with constipation. Best Pract Res Clin Gastroenterol. 2011;25(1):19–27.
National Institute for Health and Care Excellence (NICE). Clinical management of idiopathic constipation in children and young people. Manchester: NICE; 2015.
Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258–74.
Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109(Suppl 1):S2–26.
Vitton V, Damon H, Siproudhis L. Societe Nationale Francaise de Colo-Proctologie (SNFCP). Recommendations for the management of constipation in clinical practice: 2016 [in French]. Paris: SNFCP; 2016. p. 2016.
Paquette IM, Varma M, Ternent C, et al. The American Society of Colon and Rectal Surgeons’ clinical practice guideline for the evaluation and management of constipation. Dis Colon Rectum. 2016;59(6):479–92.
Koppen IJN, Broekaert IJ, Wilschanski M, et al. Role of polyethylene glycol in the treatment of functional constipation in children. J Pediatr Gastroenterol Nutr. 2017;65(4):361–3.
Fordtran JS, Hofmann AF. Seventy years of polyethylene glycols in gastroenterology: the journey of PEG 4000 and 3350 from nonabsorbable marker to colonoscopy preparation to osmotic laxative. Gastroenterology. 2017;152(4):675–80.
Forlax® 4 g, powder for oral solution in sachet: summary of product characteristics. Boulogne-Billancourt: Ipsen Pharma; 2015.
Forlax® 10 mg (macrogol 4000), powder for oral solution in sachet: patient information leaflet. Slough: Ipsen Ltd; 2016.
Schiller LR, Emmett M, Santa Ana CA, et al. Osmotic effects of polyethylene glycol. Gastroenterology. 1988;94(4):933–41.
Winne D, Gorig H. Appearance of 14C-polyethylene glycol 4000 in intestinal venous blood: influence of osmolarity and laxatives, effect on net water flux determination. Naunyn Schmiedebergs Arch Pharmacol. 1982;321(2):149–56.
Seidman EG, Hanson DG, Walker WA. Increased permeability to polyethylene glycol 4000 in rabbits with experimental colitis. Gastroenterology. 1986;90(1):120–6.
Hammer HF, Santa Ana CA, Schiller LR, et al. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest. 1989;84(4):1056–62.
Fritz E, Hammer HF, Lipp RW, et al. Effects of lactulose and polyethylene glycol on colonic transit. Aliment Pharmacol Ther. 2005;21(3):259–68.
Herve S, Leroi AM, Mathiex-Fortunet H, et al. Effects of polyethylene glycol 4000 on 24-h manometric recordings of left colonic motor activity. Eur J Gastroenterol Hepatol. 2001;13(6):647–54.
Hudziak H, Bronowicki JP, Franck P, et al. Low-dose polyethylene glycol 4000: digestive effects. Randomized double-blind study in healthy subjects. Gastroenterol Clin Biol. 1996;20(5):418–23.
Bernier JJ, Donazzolo Y. Effect of low-dose polyethylene glycol 4000 on fecal consistency and dilution water in healthy subjects [in French]. Gastroenterol Clin Biol. 1997;21(1):7–11.
Klauser AG, Muhldorfer BE, Voderholzer WA, et al. Polyethylene glycol 4000 for slow transit constipation. Z Gastroenterol. 1995;33(1):5–8.
Mangin I, Bouhnik Y, Suau A, et al. Molecular analysis of intestinal microbiota composition to evaluate the effect of PEG and lactulose laxatives in humans. Microb Ecol Health Dis. 2002;14(1):54–62.
Bae SH. Long-term safety of PEG 4000 in children with chronic functional constipation: a biochemical perspective. Korean J Pediatr. 2010;53(7):741–4.
Bouhnik Y, Neut C, Raskine L, et al. Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. Aliment Pharmacol Ther. 2004;19(8):889–99.
Williams KC, Rogers LK, Hill I, et al. PEG 3350 administration is not associated with sustained elevation of glycol levels. J Pediatr. 2018;195:148–53.
Pelham RW, Nix LC, Chavira RE, et al. Clinical trial: single- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects. Aliment Pharmacol Ther. 2008;28(2):256–65.
Ragueneau I, Poirier JM, Radembino N, et al. Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers. Br J Clin Pharmacol. 1999;48(3):453–6.
Szojda MM, Mulder CJ, Felt-Bersma RJ. Differences in taste between two polyethylene glycol preparations. J Gastrointest Liver Dis. 2007;16(4):379–81.
Savino F, Viola S, Erasmo M, et al. Efficacy and tolerability of PEG-only laxative on faecal impaction and chronic constipation in children: a controlled double blind randomized study vs a standard PEG-electrolyte laxative. BMC Pediatr. 2012;12:178.
Couturier D. Comparative study of Forlax and Transipeg in the treatment of functional constipation in the adult [in French]. Ann Gastroenterol Hepatol (Paris). 1996;32(3):135–40.
Ratananomgkol R, Lertmaharit S, Jongpiputvanich S. Polyethylene glycol 4000 without electrolytes versus milk of magnesia for the treatment of functional constipation in infants and young children: a randomized controlled trial. Asian Biomed. 2009;3(4):391–9.
Gomes PB, Duarte MA, Melo Mdo C. Comparison of the effectiveness of polyethylene glycol 4000 without electrolytes and magnesium hydroxide in the treatment of chronic functional constipation in children [in Portuguese]. J Pediatr (Rio J). 2011;87(1):24–8.
DiPalma JA, DeRidder PH, Orlando RC, et al. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol. 2000;95(2):446–50.
McGraw T. Polyethylene glycol 3350 in occasional constipation: a one-week, randomized, placebo-controlled, double-blind trial. World J Gastrointest Pharmacol Ther. 2016;7(2):274–82.
Dipalma JA, Cleveland MV, McGowan J, et al. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol. 2007;102(7):1436–41.
DiPalma JA, Cleveland MB, McGowan J, et al. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications. South Med J. 2007;100(11):1085–90.
Nurko S, Youssef NN, Sabri M, et al. PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial. J Pediatr. 2008;153(2):254–61.
Di Palma JA, Cleveland MV, McGowan J, et al. An open-label study of chronic polyethylene glycol laxative use in chronic constipation. Aliment Pharmacol Ther. 2007;25(6):703–8.
Dupont C, Leluyer B, Amar F, et al. A dose determination study of polyethylene glycol 4000 in constipated children: factors influencing the maintenance dose. J Pediatr Gastroenterol Nutr. 2006;42(2):178–85.
Dziechciarz P, Horvath A, Szajewska H. Polyethylene glycol 4000 for treatment of functional constipation in children. J Pediatr Gastroenterol Nutr. 2015;60(1):65–8.
Qizilbash N, Mendez I. Trends in utilization and off-label use of polyethylene glycol 4000 laxatives and the prevalence of constipation in children in France. Clin Exp Gastroenterol. 2011;4:181–8.
Bekkali NLJ, Hoekman DR, Leim O, et al. Polyethylene glycol 3350 with electrolytes versus polyethylene glycol 4000 for constipation: a randomized, controlled trial. J Pediatr Gastroenterol Nutr. 2018;66(1):10–5.
Wang Y, Wang B, Jiang X, et al. Polyethylene glycol 4000 treatment for children with constipation: a randomized comparative multicenter study. Exp Ther Med. 2012;3(5):853–6.
Treepongkaruna S, Simakachorn N, Pienvichit P, et al. A randomised, double-blind study of polyethylene glycol 4000 and lactulose in the treatment of constipation in children. BMC Pediatr. 2014;14:153. https://doi.org/10.1186/471-2431-14-153 .
Dupont C, Leluyer B, Maamri N, et al. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr. 2005;41(5):625–33.
Rendeli C, Ausili E, Tabacco F, et al. Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial. Aliment Pharmacol Ther. 2006;23(8):1259–65.
Gordon M, MacDonald JK, Parker CE, et al. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2016;(8):Cd009118.
Chen SL, Cai SR, Deng L, et al. Efficacy and complications of polyethylene glycols for treatment of constipation in children: a meta-analysis. Medicine (Baltimore). 2014;93(16):e65. https://doi.org/10.1097/MD.0000000000000065 .
Lee-Robichaud H, Thomas K, Morgan J, et al. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010;(7):Cd007570.
Chaussade S, Minic M. Comparison of efficacy and safety of two doses of two different polyethylene glycol-based laxatives in the treatment of constipation. Aliment Pharmacol Ther. 2003;17(1):165–72.
Seinela L, Sairanen U, Laine T, et al. Comparison of polyethylene glycol with and without electrolytes in the treatment of constipation in elderly institutionalized patients: a randomized, double-blind, parallel-group study. Drugs Aging. 2009;26(8):703–13.
Katelaris P, Naganathan V, Liu K, et al. Comparison of the effectiveness of polyethylene glycol with and without electrolytes in constipation: a systematic review and network meta-analysis. BMC Gastroenterol. 2016;16:42. https://doi.org/10.1186/s12876-016-0457-9 .
Denis P, Teillet L, Moulias R. Long-term tolerance of Forlax®: a comparative study versus lactulose in patients with functional constipation [in French]. Gastroenterologie. 1997.
Chassagne P, Ducrotte P, Garnier P, et al. Tolerance and and long-term efficacy of polyethylene glycol 4000 Forlax compared to lactulose in elderly patients with chronic constipation. J Nutr Health Aging. 2017;21(4):429–39.
Belsey JD, Geraint M, Dixon TA. Systematic review and meta analysis: polyethylene glycol in adults with non-organic constipation. Int J Clin Pract. 2010;64(7):944–55.
Guest JF, Clegg JP, Helter MT. Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK. Curr Med Res Opin. 2008;24(7):1841–52.
Zhou L, Xia Z, Lin S, et al. A randomized controlled multicenter clinical trial on the treatment of chronic functional constipation with PEG4000. Chin J Clin Pharmacol. 2001;1:7–10.
Denis P, Lerebours E. Study of the long-term tolerance of Forlax® in 16 patients treated for an average of 17 months for chronic constipation [in French]. Med Chir Digest. 1996;25(5):1–4.
Anton Girones M, Roan Roan J, de la Hoz B, et al. Immediate allergic reactions by polyethylene glycol 4000: two cases. Allergol Immunopathol (Madr). 2008;36(2):110–2.
Nguyen VM, Petitpain N, Lovato B, et al. Anaphylaxis to macrogol: five cases reported to the Allergy Vigilance Network [in French]. Rev Fr Allergol. 2014;54(4):307–10.
Pizzimenti S, Heffler E, Gentilcore E, et al. Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy. J Allergy Clin Immunol Pract. 2014;2(3):353–4.
Savitz JA, Durning SJ. A rare case of anaphylaxis to bowel prep: a case report and review of the literature. Mil Med. 2011;176(8):944–5.
Resolor (prucalopride) tablets: summary of product characteristics. London: European Medicines Agency; 2018.